Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIT-45 in Restless Legs Syndrome
NCT01382901Phase 2Completed
- Sponsor
- American Regent, Inc.
- Start
- Mar 2006
- Primary completion
- Jul 2007
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of ferric carboxymaltose in restless legs syndrome (RLS), sponsored by American Regent, Inc.. Started Mar 2006; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT01382901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01382901.